메뉴 건너뛰기




Volumn 12, Issue 4, 2007, Pages 279-283

Gemcitabine and cisplatin for advanced urothelial carcinomas: The Ehime University Hospital experience

Author keywords

Cisplatin; Gemcitabine; Metastatic urothelial carcinoma

Indexed keywords

CISPLATIN; EPIRUBICIN; GEMCITABINE; METHOTREXATE;

EID: 34547900283     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-007-0678-6     Document Type: Article
Times cited : (7)

References (16)
  • 1
    • 0024817806 scopus 로고
    • Methotrexate, vinblastine, doxorubicine, and cisplatin for advanced transitional cell carcinoma of the urothelium
    • CN Sternberg A Yagoda HI Scher 1989 Methotrexate, vinblastine, doxorubicine, and cisplatin for advanced transitional cell carcinoma of the urothelium Cancer 64 2448 2458
    • (1989) Cancer , vol.64 , pp. 2448-2458
    • Sternberg, C.N.1    Yagoda, A.2    Scher, H.I.3
  • 2
    • 0024336983 scopus 로고
    • M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for transitional cell carcinoma: The Princess Margaret Hospital experience
    • I Tannock M Gospodarowicz J Connolly 1989 M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for transitional cell carcinoma: the Princess Margaret Hospital experience J Urol 142 289 292
    • (1989) J Urol , vol.142 , pp. 289-292
    • Tannock, I.1    Gospodarowicz, M.2    Connolly, J.3
  • 3
    • 0025325071 scopus 로고
    • Evaluation of the antitumor activity of gemcitabine (2′,2′- difluoro-2′-deoxycytidine)
    • LW Hertel GB Boder JS Kroin 1990 Evaluation of the antitumor activity of gemcitabine (2′,2′-difluoro-2′-deoxycytidine) Cancer Res 50 4417 4422
    • (1990) Cancer Res , vol.50 , pp. 4417-4422
    • Hertel, L.W.1    Boder, G.B.2    Kroin, J.S.3
  • 4
    • 0030794516 scopus 로고
    • Long term follow up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine and doxorubicin in patients with metastatic urothelial carcinoma: A cooperative group study
    • SB Saxman KJ Propert LH Einhorn 1990 Long term follow up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study J Clin Oncol 15 2564 2569
    • (1990) J Clin Oncol , vol.15 , pp. 2564-2569
    • Saxman, S.B.1    Propert, K.J.2    Einhorn, L.H.3
  • 5
    • 0025237013 scopus 로고
    • Escalated therapy for refractory urothelial tumors: Methotrexate- vinblastine-doxorubicin- cisplatin plus ongoing unglycosylated recombinant human granulocyte-macrophage colony-stimulating factor
    • CL Logothetis FH Dexeus A Sella 1990 Escalated therapy for refractory urothelial tumors: methotrexate-vinblastine-doxorubicin- cisplatin plus ongoing unglycosylated recombinant human granulocyte-macrophage colony-stimulating factor J Natl Cancer Inst 82 667 672
    • (1990) J Natl Cancer Inst , vol.82 , pp. 667-672
    • Logothetis, C.L.1    Dexeus, F.H.2    Sella, A.3
  • 6
    • 0032127772 scopus 로고    scopus 로고
    • A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder Cancer
    • V Lorusso CF Pollera M Antimi 1998 A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder Cancer Eur J Cancer 34 1208 1212
    • (1998) Eur J Cancer , vol.34 , pp. 1208-1212
    • Lorusso, V.1    Pollera, C.F.2    Antimi, M.3
  • 7
    • 0030698628 scopus 로고    scopus 로고
    • Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer
    • WM Stadler T Kuzel B Roth 1997 Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer J Clin Oncol 15 3394 3398
    • (1997) J Clin Oncol , vol.15 , pp. 3394-3398
    • Stadler, W.M.1    Kuzel, T.2    Roth, B.3
  • 8
    • 0028938652 scopus 로고
    • Advanced bladder cancer: The need to identify new agents in the post-M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin)
    • BJ Roth D Bajorin 1995 Advanced bladder cancer: the need to identify new agents in the post-M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) World J Urol 153 894 900
    • (1995) World J Urol , vol.153 , pp. 894-900
    • Roth, B.J.1    Bajorin, D.2
  • 9
    • 0033857218 scopus 로고    scopus 로고
    • Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: Results of a large, randomized, multinational, multicenter, phase III study
    • H von der Maase SW Hansen JT Roberts 2000 Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study J Clin Oncol 17 3068 3077
    • (2000) J Clin Oncol , vol.17 , pp. 3068-3077
    • Von Der Maase, H.1    Hansen, S.W.2    Roberts, J.T.3
  • 10
    • 17444437833 scopus 로고    scopus 로고
    • Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer
    • D Kaufman D Raghavan M Carducci 2000 Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer J Clin Oncol 18 1921 1927
    • (2000) J Clin Oncol , vol.18 , pp. 1921-1927
    • Kaufman, D.1    Raghavan, D.2    Carducci, M.3
  • 11
    • 0032858246 scopus 로고    scopus 로고
    • Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: A phase II trial of the National Cancer Institute of Canada Clinical Trials Group
    • MJ Moore E Winquist N Murray 1999 Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: a phase II trial of the National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 17 2876 2880
    • (1999) J Clin Oncol , vol.17 , pp. 2876-2880
    • Moore, M.J.1    Winquist, E.2    Murray, N.3
  • 13
    • 2442559185 scopus 로고    scopus 로고
    • Gemcitabine plus carboplatin; And gemcitabine, docetaxel, and carboplatin combined chemotherapy regimens in patients with metastatic urothelial carcinoma previously treated with a platinum-based regimen: Preliminary report
    • S Hoshi C Ohyama K Ono 2004 Gemcitabine plus carboplatin; and gemcitabine, docetaxel, and carboplatin combined chemotherapy regimens in patients with metastatic urothelial carcinoma previously treated with a platinum-based regimen: preliminary report Int J Clin Oncol 9 126 129
    • (2004) Int J Clin Oncol , vol.9 , pp. 126-129
    • Hoshi, S.1    Ohyama, C.2    Ono, K.3
  • 14
    • 0041429507 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer
    • HB Grossman RB Natale CM Tangen 2003 Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer N Engl J Med 349 859 866
    • (2003) N Engl J Med , vol.349 , pp. 859-866
    • Grossman, H.B.1    Natale, R.B.2    Tangen, C.M.3
  • 15
    • 0037866815 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis
    • Advanced Bladder Cancer Meta-analysis Collaboration
    • Advanced Bladder Cancer Meta-analysis Collaboration 2003 Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis Lancet 361 1927 1934
    • (2003) Lancet , vol.361 , pp. 1927-1934
  • 16
    • 20844463055 scopus 로고    scopus 로고
    • The current status of perioperative chemotherapy for invasive bladder cancer: A multiinstitutional retrospective study in Japan
    • Y Matsui H Nishiyama J Watanabe 2005 The current status of perioperative chemotherapy for invasive bladder cancer: a multiinstitutional retrospective study in Japan J Clin Oncol 10 133 138
    • (2005) J Clin Oncol , vol.10 , pp. 133-138
    • Matsui, Y.1    Nishiyama, H.2    Watanabe, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.